Keyphrases
Prostate-specific Antigen Level
100%
Radiation Therapy
100%
Radical Prostatectomy
100%
Prostate-specific Antigen
44%
Irradiation
44%
Biochemical Failure
44%
Failure Rate
33%
Pelvis
22%
Effective Treatment
11%
Gleason Score
11%
Pathologic
11%
Distant Metastasis
11%
Radiation Dose
11%
Three-dimensional Conformal Radiotherapy
11%
Prognostic Factors
11%
Group-based
11%
Treatment Toxicity
11%
High-risk Population
11%
Acute Morbidity
11%
Tumor Stage
11%
Local Recurrence
11%
Tumor Extent
11%
Post-irradiation
11%
Late Morbidity
11%
Therapy Groups
11%
Arc Rotation
11%
Pelvic Irradiation
11%
Intermediate-risk Group
11%
Low-intermediate Risk
11%
Biochemical Recurrence-free Survival
11%
Prostate Bed
11%
Pre-irradiation
11%
Consecutive Measurement
11%
Rotation Group
11%
Medicine and Dentistry
Prostate Specific Antigen
100%
Prostatectomy
100%
Radiation Therapy
100%
Biochemical Recurrence
30%
Pelvis
15%
High Risk Population
15%
Neoplasm
7%
Gleason Score
7%
Low Drug Dose
7%
Distant Metastasis
7%
Recurrent Disease
7%
Prognostic Factor
7%
Pelvic Radiotherapy
7%
Intermediate Risk Population
7%
Biochemical Failure Free Survival
7%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Specific Antigen
100%
Biochemical Recurrence
30%
Neoplasm
7%
Gleason Score
7%
Distant Metastasis
7%
Recurrent Disease
7%
Biochemical Failure Free Survival
7%